GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » YoY Rev. per Sh. Growth

Nuformix (LSE:NFX) YoY Rev. per Sh. Growth : 0.00% (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Nuformix's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2022 was 0.00%.

Nuformix's Revenue per Share for the six months ended in Sep. 2022 was £0.00.

Nuformix YoY Rev. per Sh. Growth Historical Data

The historical data trend for Nuformix's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix YoY Rev. per Sh. Growth Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial - - - -100.00 -

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nuformix YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Nuformix's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2022 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2022 )
=(Revenue per Share (A: Mar. 2022 )-Revenue per Share (A: Mar. 2021 ))/ | Revenue per Share (A: Mar. 2021 ) |
=(0-0)/ | 0 |
=N/A %

Nuformix's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2022 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2022 )
=(Revenue per Share (Q: Sep. 2022 )-Revenue per Share (Q: Sep. 2021 )) / | Revenue per Share (Q: Sep. 2021 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuformix YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Nuformix's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
LSE:PYC LSE:RENE LSE:FAB LSE:GENF AQSE:INC LSE:EVG LSE:APTA LSE:IXI LSE:CIZ LSE:OCTP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
1RT:Germany
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
https://www.nuformix.com
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.